Our priority is to customize services for each patient, providing personalized care and treatment for the best results, showing our commitment to patient well-being.
Genetic testing in assisted reproduction enables a detailed analysis of embryos prior to being transferred to the uterus. This helps to assess their chromosomal health, determine their gender, and identify any hereditary diseases. Techniques such as Comprehensive Chromosomal Screening (CCS), Pre-implantation Genetic Testing (PGT), and mutation screening ensure that informed decisions can be made, and personalized care can be provided to achieve healthy pregnancies.
HealthPlus Fertility boasts a state-of-the-art genetics laboratory that is specifically designed for conducting genetic testing on embryos that have been conceived through the process of in vitro fertilization (IVF). This cutting-edge facility enables a comprehensive evaluation of the health and genetic makeup of embryos before they are transferred into the uterus.
Following the creation of embryos via in vitro fertilization (IVF), a small number of cells are taken from each embryo to undergo genetic testing prior to being implanted into the uterus. This crucial testing offers valuable insights into the chromosomal composition of the embryos as well as the potential presence of certain genetic disorders.
Advanced Chromosomal Screening (ACS)
ACS is a thorough examination of all 24 chromosomes to determine the gender of the embryo and to identify any potential missing or extra chromosomes. This process is essential in reducing the risk of miscarriage and ensuring the health of the embryo.
Gender Identification
This screening method not only determines the gender of the embryo but also detects any chromosomal abnormalities, providing valuable information for family planning decisions. It offers a comprehensive understanding of the genetic makeup of the embryo.
Genetic Testing Before Implantation
Before the embryo is transferred, it undergoes testing for all 24 chromosomes, a process known as pre-implantation genetic testing (PGT). This ensures that only genetically healthy embryos are selected for implantation, minimizing the risk of genetic disorders.
PGS and PGD
PGS is used to screen embryos for chromosomal abnormalities, while PGD is specifically designed to diagnose genetic diseases. Both methods play a crucial role in preventing inherited conditions and ensuring the health of the embryo.
HLA Compatibility
HLA matching is used to identify embryos that are compatible with providing tissue for a sibling in need of a bone marrow or cord blood transplant, often referred to as a "Savior sibling." This process can be life-saving for the sibling in need.
Mutation and Exome Screening
Mutation screening is used to detect small gene mutations that cause specific genetic diseases, while exome screening assesses interactions among tens of thousands of genes to identify hereditary conditions. These screenings provide valuable insights into potential genetic risks and conditions.
Blood Tests
HealthPlus Fertility provides a wide range of genetic testing options, including premarital and preconception screenings, to help individuals understand their risk of passing on hereditary diseases to their children.
By offering these services, we aim to give couples peace of mind, especially those with a family history of genetic disorders, as they navigate their fertility journey. With the information obtained from these blood tests, individuals can make informed decisions and receive personalized care tailored to their specific needs and circumstances
Discover unique and personalized deals designed specifically for you at HealthPlus Fertility. Whether it's reduced consultation fees, comprehensive packages, or exclusive events, take advantage of these offers to make your health a top priority. Don't miss out on the chance to invest in your well-being with these special opportunities.